Safety study of nonoxynol-9 as a vaginal microbicide: Evidence of adverse effects

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 17, Issue 4, 1998, Pages 327-331

  Stafford, Michael K ^a   Ward, Helen ^b   Flanagan, Adrienne ^b   Rosenstein, Isobel J ^a   Taylor Robinson, David ^a   Smith, J Richard ^a   Weber, Jonathan ^a   Kitchen, Valerie S ^a,b  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Inflammatory response; Lactobacillus spp.; Nonoxynol 9; Vaginal microbicide

Indexed keywords

ANTIVIRUS AGENT; FLUCONAZOLE; METRONIDAZOLE; NONOXINOL 9; SPERMICIDAL AGENT;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CANDIDIASIS; CLINICAL ARTICLE; CLINICAL TRIAL; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; GENITAL ULCER; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVAGINAL DRUG ADMINISTRATION; LACTOBACILLUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; TREATMENT OUTCOME; VAGINA FLORA; VAGINITIS; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS; LACTOBACILLUS;

EID: 0031891991     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199804010-00006     Document Type: Article

References (21)

1. Elias JE, Heise L. Challenges for the development of female-controlled vaginal microbicides. AIDS 1994;8:1-9.
2. Hicks DR, Martin LS, Getchell JP, et al. Inactivation of HTLV-III/LAV infected cultures of normal lymphocytes by nonoxynol 9 in vitro. Lancet 1985;2:1422-1423.
3. Malkovsky M, Newell A, Dalgleish AG. Inactivation of HIV by nonoxynol-9. Lancet 1988;1:645.
4. Singh B, Cutler JC, Utidijan HM. I. Studies on the development of a vaginal preparation providing both prophylaxis against venereal disease and other genital infections and contraception. II. Effect in vitro of vaginal contraceptive and non-contraceptive preparations on Treponema pallidum and Neisseria gonorrhoeae. Br J Vener Dis 1972;48:57-64.
5. Postic B, Singh B, Squeglia NL, Guevarra LO. Inactivation of clinical isolates of Herpesvirus hominis, types 1 and 2, by chemical contraceptives. Sex Trans Dis 1978;5:22-4.
6. Jennings R, Clegg A. The inhibitory effect of spermicidal agents on replication of HSV-2 and HIV-1 in vitro. J Antimicrob Chemother 1993;32:71-82.
7. O'Connor T, Kinchington D, Kangro H, et al. The activity of candidate virucidal agents, low pH and genital secretions against HIV 1 in vitro. Int J STD AIDS 1995;6:267-72.
8. McGroarty JA, Chung S, Reid G, Bruce AW. Influence of the spermicidal compound nonoxynol-9 on the growth and adhesion of urogenital bacteria in vitro. Curr Microbiol 1990;21:219-23.
9. Klebanoff SJ, Coombs RW. Virucidal effect of Laclobacillus acidophillus on human immunodeficiency virus types: possible role of heterosexual transmission. J Exp Med 1991;174:289-92.
10. Jick H, Hannan MT, Sterachis A, et al. Vaginal spermicides and gonorrhoea. JAMA 1982;248:1619-21.
11. Louv WC, Austin H, Alexander WJ, Stagno S, Cheeks J. A clinical trial of nonoxynol-9 for preventing gonococcal and chlamydial infections. J Infect Dis 1988;158:518-23.
12. Rosenberg MJ, Feldblum PJ, Rojanapithayakorn W, Sawasdivorn W. The contraceptive sponge's protection against Chlamydia trachomatis and Neisseria gonorrhoeae. Sex Transm Dis 1987;14: 147-152.
13. Weir SS, Roddy RE, Zekeng L, Feldblum PJ. Nonoxynol-9 use, genital ulcers, and HIV infection in a cohort of sex workers. Genitourin Med 1995;71:78-81.
14. Niruthisard S, Roddy RE, Chutivongse S, The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa. Sex Transm Dis 1991;18:176-9.
15. Roddy RE, Cordero M, Cordero C, Fortney JA. A dosing study of nonoxynol-9 and genital irritation. Int J STD AIDS 1993;4:165-70.
16. Kreiss J, Ruminjo I, Ngugi E, et al. Efficacy of nonoxynol-9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA 1992;268:477-82.
17. Roddy RE, Zekeng L, Ryan KA, et al. A randomized controlled trial of the effect of N-9 film use in male-to-female transmission of HIV-1[abstract 215,3]. National Conference on Women and HIV, Los Angeles, CA, May 4-7, 1997.
18. Manual for Standardisation of Colposcopy for the Evaluation of Vaginally Administered Products. WHO Global Programme on AIDS.
19. Stafford MK, Cain D, Rosenstein I, Fontaine, EA, et al. A placebocontrolled, double-blind prospective study in healthy female volunteers of dextrin sulphate gel. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:213-8.
20. Spria AI, Marx PA, Patterson BK, et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med 1996;183:215-25.
21. Miller CJ, Alexander NJ, Sutjipto S, et al. Effect of virus dose and nonoxynol-9 on the genital transmission of SIV in rhesus macaques. J Med Primatol 1990;19:401-9.